Literature DB >> 7904240

Secretory leucocyte proteinase inhibitor is produced by human articular cartilage chondrocytes and intervertebral disc fibrochondrocytes.

A S Jacoby1, J Melrose, B G Robinson, V J Hyland, P Ghosh.   

Abstract

The objective of this study was to examine the expression of the secretory leucocyte proteinase inhibitor (SLPI) gene by human articular cartilage chondrocytes and intervertebral disc fibrochondrocytes. RNA was extracted from human articular cartilage chondrocytes, synovial fibroblasts and fibrochondrocytes of the annulus fibrosus. Expression was analysed by Northern blotting and hybridisation to a SLPI RNA probe. SLPI was isolated from chondrocyte culture supernatant by gel-permeation and cation-exchange chromatography and examined by a solid-phase enzyme-linked immunofiltration assay for SLPI and by SDS/PAGE using Western blotting with polyclonal IgG samples against bronchial mucus leucocyte proteinase inhibitor and SLPI. This identified biochemically and immunologically the major serine proteinase inhibitory protein synthesised by chondrocytes as SLPI. Secretory leucocyte proteinase inhibitor mRNA was detected in RNA preparations from articular cartilage chondrocytes and annulus fibrosus fibrochondrocytes. The results presented here allowed us to deduce that human articular cartilage chondrocytes and intervertebral disc fibrochondrocytes synthesized SLPI whereas human synovial fibroblasts did not.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904240     DOI: 10.1111/j.1432-1033.1993.tb18452.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  5 in total

1.  Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases.

Authors:  Y Zhang; D L DeWitt; T B McNeely; S M Wahl; L M Wahl
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

Review 2.  The essential anti-angiogenic strategies in cartilage engineering and osteoarthritic cartilage repair.

Authors:  Song Chen; Yixuan Amy Pei; Ming Pei
Journal:  Cell Mol Life Sci       Date:  2022-01-14       Impact factor: 9.261

3.  Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis.

Authors:  X y Song; L Zeng; W Jin; J Thompson; D E Mizel; K Lei; R C Billinghurst; A R Poole; S M Wahl
Journal:  J Exp Med       Date:  1999-08-16       Impact factor: 14.307

4.  Osteochondral angiogenesis and increased protease inhibitor expression in OA.

Authors:  R E Fransès; D F McWilliams; P I Mapp; D A Walsh
Journal:  Osteoarthritis Cartilage       Date:  2009-12-21       Impact factor: 6.576

5.  Secretory leukocyte protease inhibitor is an inducible antimicrobial peptide expressed in Staphylococcus aureus endophthalmitis.

Authors:  Victor E Reviglio; Ruben H Sambuelli; Alejandra Olmedo; Micaela Falco; Jose Echenique; Terrence P O'Brien; Irene C Kuo
Journal:  Mediators Inflamm       Date:  2007       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.